Molecure S.A. (WSE:MOC)
7.98
-0.07 (-0.87%)
Apr 10, 2025, 4:43 PM CET
Molecure Revenue
In the year 2024, Molecure had annual revenue of 2.92M PLN, down -20.08%. Molecure had revenue of 1.81M in the quarter ending December 31, 2024, with 339.69% growth.
Revenue
2.92M
Revenue Growth
-20.08%
P/S Ratio
55.71
Revenue / Employee
27.80K
Employees
111
Market Cap
162.64M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.92M | -733.54K | -20.08% |
Dec 31, 2023 | 3.65M | -3.86M | -51.39% |
Dec 31, 2022 | 7.51M | 6.35M | 543.32% |
Dec 31, 2021 | 1.17M | -123.74M | -99.07% |
Dec 31, 2020 | 124.91M | 122.90M | 6,100.72% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
NEUCA | 12.61B |
Synektik Spólka Akcyjna | 556.63M |
Voxel | 507.77M |
Celon Pharma | 209.54M |
Selvita | 345.76M |
Ryvu Therapeutics | 101.96M |
Centrum Medyczne ENEL-MED | 680.32M |
Scope Fluidics | 119.00K |